Featured Article: Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model

Experimental Biology and Medicine

Volumn 239, Issue 3, 2014, Pages 356-365

  Shi, Bei ^a   Long, Xianping ^a   Zhao, Ranzun ^a   Liu, Zhijiang ^a   Wang, Dongmei ^a   Xu, Guanxue ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

cardiac function; carotid angioplasty; Mesenchymal stem cells; myocardial infarction; neointima; receptor activity modifying protein 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CYCLINE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; ACTIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CD31 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; RAMP1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NEOINTIMA; NONHUMAN; RABBIT; WESTERN BLOTTING; ANGIOGENESIS; ANGIOPLASTY; ANIMAL; BIOSYNTHESIS; CAROTID ANGIOPLASTY; CAROTID ARTERY; CYTOLOGY; GENETICS; HEART; HEART FUNCTION TEST; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RECEPTOR ACTIVITY-MODIFYING PROTEIN-1; VASCULAR SMOOTH MUSCLE;

CARDIAC FUNCTION; CAROTID ANGIOPLASTY; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; NEOINTIMA; RECEPTOR ACTIVITY-MODIFYING PROTEIN-1;

ACTINS; ANGIOPLASTY; ANIMALS; ANTIGENS, CD31; CALCITONIN GENE-RELATED PEPTIDE; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL PROLIFERATION; GREEN FLUORESCENT PROTEINS; HEART; HEART FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL INFARCTION; NEOINTIMA; NEOVASCULARIZATION, PHYSIOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

EID: 84896044877     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213517619     Document Type: Article

References (48)

1. Choi YH,Kurtz A,Stamm C.Mesenchymal stem cells for cardiac cell therapy.Hum Gene Ther. 2011;22:3-17.
2. Williams AR,Hare JM.Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease.Circ Res. 2011;109:923-40.
3. Dimmeler S,Zeiher AM.Cell therapy of acute myocardial infarction: open questions.Cardiology. 2009;113:155-60.
4. Mathur A,Martin JF.Stem cells and repair of the heart.Lancet. 2004;364:183-92.
5. Leeper NJ,Hunter AL,Cooke JP.Stem cell therapy for vascular regeneration: Adult, embryonic, and induced pluripotent stem cells.Circulation. 2010;122:517-26.
6. Kidd S,Spaeth E,Klopp A,Andreeff M,Hall B,Marini FC.The (in) auspicious role of mesenchymal stromal cells in cancer: Be it friend or foe.Cytotherapy. 2008;10:657-67.
7. Rodriguez-Menocal L,St-Pierre M,Wei Y,Khan S,Mateu D,Calfa M,Rahnemai-Azar AA,Striker G,Pham SM,Vazquez-Padron RI.The origin of post-injury neointimal cells in the rat balloon injury model.Cardiovasc Res. 2009;81:46-53.
8. Hillebrands JL,Klatter FA,Rozing J.Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis.Arterioscler Thromb Vasc Biol. 2003;23:380-7.
9. Inoue T,Sata M,Hikichi Y,Sohma R,Fukuda D,Uchida T,Shimizu M,Komoda H,Node K.Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis.Circulation. 2007;115:553-61.
10. Nagaya N,Kangawa K,Itoh T,Iwase T,Murakami S,Miyahara Y,Fujii T,Uematsu M,Ohgushi H,Yamagishi M,Tokudome T,Mori H,Miyatake K,Kitamura S.Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.Circulation. 2005;112:1128-35.
11. Zeng B,Ren X,Lin G,Zhu C,Chen H,Yin J,Jiang H,Yang B,Ding D.Paracrine action of HO-1-modified mesenchymal stem cells mediates cardiac protection and functional improvement.Cell Biol Int. 2008;32:1256-64.
12. Cheng Z,Ou L,Zhou X,Li F,Jia X,Zhang Y,Liu X,Li Y,Ward CA,Melo LG,Kong D.Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.Mol Ther. 2008;16:571-9.
13. Li W,Ma N,Ong LL,Nesselmann C,Klopsch C,Ladilov Y,Furlani D,Piechaczek C,Moebius JM,Lützow K,Lendlein A,Stamm C,Li RK,Steinhoff G.Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.Stem Cells. 2007;25:2118-27.
14. Hay DL,Poyner DR,Sexton PM.GPCR modulation by RAMPs.Pharmacol Ther. 2006;109:173-97.
15. Deng W,St Hilaire RC,Chattergoon NN,Jeter JR,Kadowitz PJ.Inhibition of vascular smooth muscle cell proliferation in vitro by genetically engineered marrow stromal cells secreting calcitonin gene-related peptide.Life Sci. 2006;78:1830-8.
16. Eglon MN,Duffy AM,O'Brien T,Strappe PM.Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography.J Gene Med. 2009;11:978-89.
17. Liu H,Fan H,Toh SL,Goh JC.A comparison of rabbit mesenchymal stem cells and anterior cruciate ligament fibroblasts responses on combined silk scaffolds.Biomaterials. 2008;29:1443-53.
18. Izumi T,Saito Y,Kishimoto I,Harada M,Kuwahara K,Hamanaka I,Takahashi N,Kawakami R,Li Y,Takemura G,Fujiwara H,Garbers DL,Mochizuki S,Nakao K.Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury.J Clin Invest. 2001;108:203-13.
19. Sata M,Maejima Y,Adachi F,Fukino K,Saiura A,Sugiura S,Aoyagi T,Imai Y,Kurihara H,Kimura K,Omata M,Makuuchi M,Hirata Y,Nagai R.A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia.J Mol Cell Cardiol. 2000;32:2097-104.
20. Chen MY,Lie PC,Li ZL,Wei X.Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.Exp Hematol. 2009;37:629-40.
21. Duffy GP,Ahsan T,O'Brien T,Barry F,Nerem RM.Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro.Tissue Eng Part A. 2009;15:2459-70.
22. Hattan N,Kawaguchi H,Ando K,Kuwabara E,Fujita J,Murata M,Suematsu M,Mori H,Fukuda K.Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice.Cardiovasc Res. 2005;65:334-44.
23. Hakuno D,Fukuda K,Makino S,Konishi F,Tomita Y,Manabe T,Suzuki Y,Umezawa A,Ogawa S.Bone marrow-derived regenerated cardiomyocytes (CMG Cells) express functional adrenergic and muscarinic receptors.Circulation. 2002;105:380-6.
24. Gong Z,Niklason LE.Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs).FASEB J. 2008;22:1635-48.
25. Li Z,Guo J,Chang Q,Zhang A.Paracrine role for mesenchymal stem cells in acute myocardial infarction.Biol Pharm Bull. 2009;32:1343-6.
26. Meirelles Lda S,Fontes AM,Covas DT,Caplan AI.Mechanisms involved in the therapeutic properties of mesenchymal stem cells.Cytokine Growth Factor Rev. 2009;20:419-27.
27. Psaltis PJ,Zannettino AC,Worthley SG,Gronthos S.Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair.Stem Cells. 2008;2:2201-10.
28. Afzal MR,Haider HKh,Idris NM,Jiang S,Ahmed RP,Ashraf M.Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kappaB signaling.Antioxid Redox Signal. 2010;12:693-702.
29. Yao Y,Zhang F,Wang L,Zhang G,Wang Z,Chen J,Gao X.Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction.J Biomed Sci. 2009;16:74-74.
30. Wisel S,Khan M,Kuppusamy ML,Mohan IK,Chacko SM,Rivera BK,Sun BC,Hideg K,Kuppusamy P.Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.J Pharmacol Exp Ther. 2009;329:543-50.
31. Pasha Z,Wang Y,Sheikh R,Zhang D,Zhao T,Ashraf M.Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.Cardiovasc Res. 2008;77:134-42.
32. Huang J,Zhang Z,Guo J,Ni A,Deb A,Zhang L,Mirotsou M,Pratt RE,Dzau VJ.Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.Circ Res. 2010;106:1753-62.
33. Alfaro MP,Vincent A,Saraswati S,Thorne CA,Hong CC,Lee E,Young PP.sFRP2 suppression of bone morphogenic protein (BMP) and Wnt signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair.J Biol Chem. 2010;285:35645-53.
34. Fan L,Lin C,Zhuo S,Chen L,Liu N,Luo Y,Fang J,Huang Z,Lin Y,Chen J.Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction.Eur J Heart Fail. 2009;11:1023-30.
35. Forte A,Finicelli M,Mattia M,Berrino L,Rossi F,De Feo M,Cotrufo M,Cipollaro M,Cascino A,Galderisi U.Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids.J Cell Physiol. 2008;217:789-99.
36. Wen Z,Zheng S,Zhou C,Wang J,Wang T.Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.J Cell Mol Med. 2011;15:1032-43.
37. Nguyen BK,Maltais S,Perrault LP,Tanguay JF,Tardif JC,Stevens LM,Borie M,Harel F,Mansour S,Noiseux N.Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors.J Cardiovasc Transl Res. 2010;3:547-58.
38. Mishima T,Ito Y,Hosono K,Tamura Y,Uchida Y,Hirata M,Suzsuki T,Amano H,Kato S,Kurihara Y,Kurihara H,Hayashi I,Watanabe M,Majima M.Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice.Am J Physiol Heart Circ Physiol. 2011;300:H431-9.
39. Toda M,Suzuki T,Hosono K,Hayashi I,Hashiba S,Onuma Y,Amano H,Kurihara Y,Kurihara H,Okamoto H,Hoka S,Majima M.Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide.Proc Natl Acad Sci USA. 2008;105:13550-5.
40. Gnecchi M,Zhang Z,Ni A,Dzau VJ.Paracrine mechanisms in adult stem cell signaling and therapy.Circ Res. 2008;103:1204-19.
41. Meirelles Lda S,Fontes AM,Covas DT,Caplan AI.Mechanisms involved in the therapeutic properties of mesenchymal stem cells.Cytokine Growth Factor Rev. 2009;20:419-27.
42. Zhang Z,Dickerson IM,Russo AF.Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells.Endocrinology. 2006;147:1932-40.
43. Ghajar CM,Blevins KS,Hughes CC,George SC,Putnam AJ.Mesenchymal stem cells enhance angiogenesis in mechanically viable prevascularized tissues via early matrix metalloproteinase upregulation.Tissue Eng. 2006;12:2875-88.
44. Nesselmann C,Ma N,Bieback K,Wagner W,Ho A,Konttinen YT,Zhang H,Hinescu ME,Steinhoff G.Mesenchymal stem cells and cardiac repair.J Cell Mol Med. 2008;12:1795-810.
45. Raynaud CM,Rafii A.The necessity of a systematic approach for the use of MSCs in the clinical setting.Stem Cells Int. 2013;2013:892340-50.
46. Shabbir A,Zisa D,Suzuki G,Lee T.Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: A noninvasive therapeutic regimen.Am J Physiol Heart Circ Physiol. 2009;296:H1888-97.
47. Zheng S,Li W,Xu M,Bai X,Zhou Z,Han J,Shyy JY,Wang X.Calcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase.Am J Physiol Cell Physiol. 2010;299:C1485-92.
48. Takaoka M,Uemura S,Kawata H,Imagawa K,Takeda Y,Nakatani K,Naya N,Horii M,Yamano S,Miyamoto Y,Yoshimasa Y,Saito Y.Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery.Arterioscler Thromb Vasc Biol. 2006;26:2083-9.